Skip to content

Comment on Toshiba device tests cancer types from a drop of bloodparent

Comments

It doesn't have to instantly and directly kill somebody to be bad in aggregate.

This kind of analysis has been done, most memorably for breast cancer screening. The conclusion I recall was that it did more harm than good a few years ago (opportunity cost of unnecessary spending, pain and complications of biopsy, unnecessary mastectomy, psychological damage, etc. etc.). The follow-up tests and analysis also have an error rate and no treatment is zero cost.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.